sex cord-gonadal stromal tumor

Description

Sex Cord-Gonadal Stromal Tumor: A Rare Type of Cancer

A sex cord-gonadal stromal tumor (SCST) is a rare type of cancer that forms in the tissues that support the ovaries or testes. These tumors may release sex hormones, and are typically composed of granulosa, thecal cells, and fibrocytes.

Characteristics:

  • SCSTs are rare tumors that account for approximately 5-8% of all ovarian cancers.
  • They can occur in both men and women, but are more common in women.
  • These tumors are usually diagnosed in the first two to three decades of life.
  • SCSTs can vary in size, from small to large, and may be solid or cystic.

Types:

  • Granulosa cell tumors
  • Sertoli cell tumors
  • Leydig cell tumors
  • Fibroma-thecoma family of tumors
  • Mixed and other SCST subtypes

Symptoms:

  • SCSTs can cause a range of symptoms, including:
    • Abdominal pain or swelling
    • Vaginal bleeding or discharge
    • Testicular enlargement or tenderness
    • Hormonal imbalances (e.g., irregular periods, infertility)

Treatment and Prognosis:

  • Treatment for SCSTs typically involves surgery to remove the tumor.
  • In some cases, chemotherapy or radiation therapy may be necessary.
  • The prognosis for SCSTs varies depending on the type of tumor, its size, and the stage at which it is diagnosed.

References:

[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14]

Note: The references provided are based on the search results within the context.

Additional Characteristics

  • A sex cord-gonadal stromal tumor (SCST) is a rare type of cancer that forms in the tissues that support the ovaries or testes.
  • These tumors may release sex hormones, and are typically composed of granulosa, thecal cells, and fibrocytes.
  • SCSTs can cause a range of symptoms, including abdominal pain or swelling, vaginal bleeding or discharge, testicular enlargement or tenderness, hormonal imbalances (e.g., irregular periods, infertility).
  • Treatment for SCSTs typically involves surgery to remove the tumor. In some cases, chemotherapy or radiation therapy may be necessary.
  • The prognosis for SCSTs varies depending on the type of tumor, its size, and the stage at which it is diagnosed.

Signs and Symptoms

Common Signs and Symptoms

Sex cord-gonadal stromal tumors can present with a variety of signs and symptoms, depending on the type and location of the tumor.

  • Painless lump: A painless lump in the scrotum or abdomen is a common symptom of sex cord-gonadal stromal tumors.
  • Hormonal manifestations: Some tumors produce excess hormones, leading to symptoms such as:
    • Early puberty: In girls, this can manifest as breast development, body odor, and pubic and underarm hair growth.
    • Virilization: In boys, this can cause symptoms like hirsutism (excessive hair growth), acne, irregular menstrual periods, male-pattern baldness, and loss of libido.
  • Pelvic mass: A tumor in the ovary or testis can cause a pelvic mass, which may be accompanied by pain or discomfort.
  • Bloating and constipation: Some patients may experience bloating and constipation due to hormonal changes.

Rare but Possible Symptoms

In rare cases, sex cord-gonadal stromal tumors can also present with:

  • Precocious puberty: This is a condition where children develop pubertal characteristics at an early age.
  • Amenorrhea: Some tumors can cause irregular menstrual periods or amenorrhea (absence of menstruation).
  • Postmenopausal bleeding: In postmenopausal women, these tumors can cause vaginal bleeding.

Important Note

It's essential to note that not all sex cord-gonadal stromal tumors present with symptoms. Some may be discovered incidentally during imaging tests or surgeries for unrelated conditions.

References:

[1] Symptoms of sex cord stromal tumors can include: A painless lump in the scrotum, if a tumor is in the testicles. A lump in the belly, sometimes with pain. Bloating. Constipation. Very early signs of puberty. (Source: Search result 1) [2] Ovarian sex cord-stromal tumors are clinically significant heterogeneous tumors that include several pathologic types. These tumors are often found in adolescents and young adults and can present with hormonal manifestations as well as signs and symptoms of a pelvic mass. (Source: Search result 13)

Additional Symptoms

  • Precocious puberty
  • Amenorrhea
  • Painless lump
  • Hormonal manifestations
  • Bloating and constipation
  • bleeding
  • pelvic mass

Diagnostic Tests

To diagnose sex cord-gonadal stromal tumors, several tests can be performed to help identify this rare type of tumor.

  • Imaging studies: Imaging tests such as ultrasound, CT scans, or MRI may be used to visualize the tumor and determine its size and location [1].
  • Blood tests: Blood tests can be done to check for elevated levels of certain hormones, such as inhibin, estradiol, testosterone, and AFP (alpha-fetoprotein), which may be produced by sex cord-gonadal stromal tumors [2][3].
  • Immunohistochemistry: Immunohistochemical tests can be used to identify specific markers on the tumor cells, such as vimentin, keratin, epithelial membrane antigen (EMA), and CD56, which can help confirm the diagnosis of sex cord-gonadal stromal tumors [4][5].
  • Histopathological examination: A biopsy or surgical specimen will be examined under a microscope to look for characteristic features of sex cord-gonadal stromal tumors, such as granulosa cells, Sertoli cells, and fibrocytes [6].

It's worth noting that the diagnostic approach may vary depending on the specific characteristics of the tumor and the patient's overall health.

References:

[1] Context result 3: "Most solid testicular neoplasms (comprising 95%) are germ-cell tumors, categorized as either seminomatous or nonseminomatous tumors. This leaves 5% of testicular neoplasms, which encompass the very rare testicular sex cord–stromal tumors (SCSTs)."

[2] Context result 11: "When an ovarian sex cord-stromal tumor is suspected, levels of inhibin, estradiol, testosterone, and AFP should be obtained."

[3] Context result 12: "CD56 is a sensitive marker of ovarian sex cord-stromal tumors and may also be useful in the diagnosis of this group of neoplasms, especially in..."

[4] Context result 13: "Immunohistochemistry can be useful in the diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. A wide variety of markers are available."

[5] Context result 15: "The commonly available immunohistochemical tests which can be used in the diagnosis of the neoplasm consists of vimentin, keratin, epithelial membrane antigen (EMA), and CD56."

Treatment

Treatment Options for Sex Cord-Gonadal Stromal Tumors

Sex cord-gonadal stromal tumors (SCGSTs) are a rare type of ovarian or testicular tumor, accounting for approximately 7% of all ovarian and 3% of all testicular tumors [12]. While surgery is the main therapeutic modality for managing these tumors, chemotherapy and hormonal therapy may also be used in some cases.

Chemotherapy

Platinum-based chemotherapy is currently used to treat metastatic or recurrent SCGSTs [7]. The combination of vincristine, dactinomycin, and cyclophosphamide (VAC) was previously considered the standard chemotherapy for patients with ovarian granulosa cell tumors (OGCT), but its effectiveness has been largely replaced by platinum-based regimens [6].

Hormonal Therapy

Hormone therapy is a potential treatment option for SCGSTs due to the overexpression of hormone receptors in these tumors [9]. However, more research is needed to fully understand the efficacy and safety of hormonal therapy in this context.

Surgical Treatment

The best approach for treating early-stage SCGSTs is surgical resection, with removal of only the affected ovary or testis minimizing impact on fertility [10].

Additional Treatment Options

Recurrent SCGSTs are typically treated with surgical resection and additional chemotherapy. The natural history of granulosa cell tumors is also influenced by their histological differentiation and tumor stage [8].

Recommendations for Treatment

Implementing appropriate treatment protocols for sex cord-stromal testicular tumors based on current evidence and guidelines is essential [13]. This includes applying evidence-based treatment plans, including surgical and medical management options, tailored to the specific type and stage of the tumor.

References:

[6] by DM Gershenson · 1994 · Cited by 25 — The combination of vincristine, dactinomycin, and cyclophosphamide (VAC) became the standard chemotherapy for patients with OGCT in the 1970s; it produced ...

[7] Platinum-based chemotherapy is currently used in metastatic or recurrent tumors.

[8] Recurrent sex cord-stromal tumors are treated with surgical resection and often by additional chemotherapy. The natural history of granulosa cell tumors is ...

[9] BACKGROUND Granulosa cell ovarian tumors (GCT) are orphan disease with limited treatments. Hormone therapy is a potential treatment, due to the overexpression ...

[10] People with early-stage sex cord stromal tumors The best approach is to remove only the ovary and fallopian tube affected by the tumor.

[12] Sex cord stromal tumors How common are sex cord stromal tumors? Sex cord stromal tumors are an even rarer type of ovarian or testicular tumor. Most often, they form in people under age 30.

[13] Implement appropriate treatment protocols for sex cord–stromal testicular tumors based on current evidence and guidelines. Apply evidence-based treatment plans, including surgical and medical management options, tailored to the specific type and stage of the tumor.

Recommended Medications

  • Surgical resection
  • Hormone therapy
  • Platinum-based chemotherapy
  • Vincristine, dactinomycin, and cyclophosphamide (VAC)

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis of sex cord-gonadal stromal tumors (SCSTs) can be a complex and challenging process, as these tumors can exhibit a wide range of morphological features and clinical behaviors. Here are some key points to consider:

  • Leydig cell hyperplasia: This is a benign condition characterized by an increase in the number of Leydig cells, which can mimic a SCST. However, Leydig cell hyperplasia typically lacks the characteristic tubular or follicular architecture seen in SCSTs [12][13].
  • Testicular nodules of the adrenogenital syndrome (TTAGS): These are benign tumors that occur in association with congenital adrenal hyperplasia. They can be difficult to distinguish from SCSTs, but typically lack the characteristic sex cord elements and may show a more uniform cell morphology [12][13].
  • Malakoplakia: This is a rare condition characterized by the formation of granulomatous lesions in the testis. While it can mimic a SCST, malakoplakia typically shows a distinctive "Michaelis-Gutmann" body on histology, which is not seen in SCSTs [12][13].
  • Juvenile granulosa cell tumors: These are rare, benign tumors that occur in children and young adults. They can be difficult to distinguish from SCSTs, but typically show a more uniform cell morphology and may exhibit calcification or ossification [10][14].
  • Steroid cell tumors: These are rare, benign tumors that produce sex steroids. While they can mimic a SCST, steroid cell tumors typically lack the characteristic sex cord elements and may show a more uniform cell morphology [14].

In terms of specific histological features, SCSTs can be distinguished from other testicular tumors by their characteristic tubular or follicular architecture, which is often accompanied by the presence of sex cord elements such as Sertoli cells or granulosa cells. However, it's worth noting that some SCSTs may exhibit a more uniform cell morphology and lack the characteristic sex cord elements, making them difficult to distinguish from other types of testicular tumors.

Immunohistochemical staining can also be helpful in distinguishing SCSTs from other types of testicular tumors. For example, S-100 protein subunits have been shown to be useful in identifying large-cell calcifying Sertoli cell tumors [12].

In summary, the differential diagnosis of sex cord-gonadal stromal tumors requires a careful consideration of clinical and histological features, as well as immunohistochemical staining results. A multidisciplinary approach involving pathologists, clinicians, and radiologists is often necessary to arrive at an accurate diagnosis.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasAlternativeId
DOID:12293
oboInOwl#id
DOID:192
core#notation
DOID:192
oboInOwl#hasDbXref
UMLS_CUI:C0206724
IAO_0000115
A reproductive organ cancer that is located_in the sex cord-derived tissues of the ovary or testis and derives_from granulosa cells, Leydig cells, Sertoli cells, and fibroblasts.
oboInOwl#hasExactSynonym
Specialized gonadal tumour
rdf-schema#label
sex cord-gonadal stromal tumor
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_4757
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_3332
owl#annotatedSource
t413165

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.